DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 1Olpha
03 2NanoAlvand
04 2Accord healthcare
05 1Actavis Inc
06 1Adalvo
07 2Apotex Inc
08 24Astellas Pharma
09 1Auro Pharma Inc
10 1Aurogen South Africa (Pty) Ltd
11 2CLONMEL HLTHCARE
12 1Dr Reddy's Laboratories (Pty) Ltd
13 1Eurolab
14 1Genex Pharma
15 4Hexal AG
16 2Hikma Pharmaceuticals
17 2Intas Pharmaceuticals
18 1JAMP PHARMA
19 1Norameda
20 2PharOS Ltd
21 2Pinnacle Life Science
22 3Pluviaendo
23 8STADA Arzneimittel
24 1Sakar Healthcare
25 18Sandoz B2B
26 1Sinotherapeutics
27 2Spirig Healthcare
28 4Teva Pharmaceutical Industries
29 1Unichem Laboratories Limited
30 3Vama Lifecare
31 7Viatris
32 2Zentiva
33 3Zydus Pharmaceuticals
01 4CAP
02 5CAPSULE
03 4CAPSULE;ORAL
04 7Capsule
05 1Capsules
06 1Enzalutamide 40Mg 112 Unita' Oral Use
07 51Film Coated Tablet
08 8Film-Coated Tablet
09 2Oral
10 4Soft Capsule
11 1Soft Gelatin Capsule
12 3TABLET
13 6TABLET;ORAL
14 9Tablet
15 1Tablet, Soft Gelatine Capsule
16 3capsule
01 6Allowed
02 16Approved
03 9Authorised
04 13Authorized
05 3DISCN
06 1Dossier Readiness: Q4 2025
07 4Generic
08 1Marketed
09 1Not Marketed
10 1Originator
11 5PRESCRIPTION
12 20Prescription
13 5RX
14 25Blank
01 1APO-ENZALUTAMIDE
02 1AURO-ENZALUTAMIDE
03 1ENLUTOZA
04 10ENZALUTAMIDE
05 3ENZAVAM
06 2Enzalutamid Sandoz
07 1Enzalutamid Spirig HC
08 1Enzalutamida Accord
09 2Enzalutamida Sandoz
10 2Enzalutamida Sandoz Farmaceutica
11 2Enzalutamida Stada
12 2Enzalutamida Viatris
13 4Enzalutamide
14 1Enzalutamide Accord
15 1Enzalutamide Adalvo
16 2Enzalutamide Clonmel
17 2Enzalutamide Ebewe
18 2Enzalutamide Hexal
19 1Enzalutamide Norameda
20 2Enzalutamide Pharos
21 6Enzalutamide Sandoz
22 1Enzalutamide Spirig HC
23 4Enzalutamide Stada
24 2Enzalutamide Teva
25 2Enzalutamide Tevagen
26 5Enzalutamide Viatris
27 2Enzalutamide Zentiva
28 2Enzalutamide "Hexal"
29 2Enzalutamide "Sandoz"
30 2Enzalutamide "Stada"
31 1Enzutix
32 1JAMP ENZALUTAMIDE
33 1REDDY-ENZALUTAMIDE
34 1SAMENZA
35 2Tenzala
36 4XTANDI
37 19Xtandi
38 1Xtandi 40 mg
39 1Zilade
40 8Blank
01 3Australia
02 5Canada
03 9Denmark
04 11Estonia
05 12India
06 2Iran
07 1Italy
08 1Latvia
09 9Malta
10 2Norway
11 4South Africa
12 13Spain
13 16Sweden
14 6Switzerland
15 3Turkey
16 13USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Enzalutamide
Dosage Form : Oral
Dosage Strength : 40 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q4 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q4 2025
Registration Country : Latvia
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Tenzala
Dosage Form : Film Coated Tablet
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Enzalutamide
Dosage Form : Oral
Dosage Strength : 80 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : PRESCRIPTION
Registration Country : Canada
Brand Name : REDDY-ENZALUTAMIDE
Dosage Form : CAPSULE
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number : 2558424
Regulatory Info : PRESCRIPTION
Registration Country : Canada
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Tenzala
Dosage Form : Film Coated Tablet
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2021-05-14
Application Number : 209614
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2022-04-22
Application Number : 209645
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XTANDI
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2012-08-31
Application Number : 203415
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XTANDI
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2020-08-04
Application Number : 213674
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : XTANDI
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date : 2020-08-04
Application Number : 213674
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number : 218731
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number : 218731
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2026-04-20
Application Number : 216068
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date : 2026-04-20
Application Number : 216068
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number : 219675
Regulatory Info :
Registration Country : USA
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 2024-09-26
Application Number : 209667
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number : 217322
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ENZALUTAMIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number : 217322
Regulatory Info :
Registration Country : USA
